See more : Bluegreen Vacations Holding Corporation (BVH) Income Statement Analysis – Financial Results
Complete financial analysis of Vincent Medical Holdings Limited (1612.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Vincent Medical Holdings Limited, a leading company in the Medical – Devices industry within the Healthcare sector.
- Epsilon Net S.A. (EPSIL.AT) Income Statement Analysis – Financial Results
- Chr. Hansen Holding A/S (CHR.CO) Income Statement Analysis – Financial Results
- Golden Matrix Group, Inc. (GMGI) Income Statement Analysis – Financial Results
- The Japan Wool Textile Co., Ltd. (3201.T) Income Statement Analysis – Financial Results
- Groupe MEDIA 6 (EDI.PA) Income Statement Analysis – Financial Results
Vincent Medical Holdings Limited (1612.HK)
About Vincent Medical Holdings Limited
Vincent Medical Holdings Limited, an investment holding company, researches, develops, manufactures, markets, and sells medical devices. It operates in two segments, Original Equipment Manufacturing (OEM) and Original Brand Manufacturing. The company develops medical devices focusing on respiratory products; imaging contrast media power injector disposables; and orthopedic and rehabilitation products for OEM customers. Its respiratory products portfolio includes humidification systems, nCPAP interface systems, respiratory care units, electronic air-oxygen blenders, and anesthesia systems. The company's orthopedic and rehabilitation products comprise various adjustable rehabilitation braces for support and protection, and rehabilitation of various skeletomuscular parts after injury or surgery. It also develops robotic hand training devices. Vincent Medical Holdings Limited sells its products under the Inspired Medical, Hand of Hope, and Hypnus brand names in the People's Republic of China, the United States, the Netherlands, Australia, Japan, and internationally. The company was founded in 1997 and is headquartered in Hung Hom, Hong Kong. Vincent Medical Holdings Limited is a subsidiary of Vincent Raya International Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 717.97M | 629.24M | 777.72M | 1.16B | 502.20M | 488.03M | 446.30M | 467.35M | 448.17M | 388.98M | 324.49M |
| Cost of Revenue | 495.38M | 481.41M | 533.89M | 676.60M | 340.75M | 332.42M | 296.00M | 321.59M | 308.37M | 273.91M | 236.29M |
| Gross Profit | 222.59M | 147.83M | 243.83M | 478.79M | 161.45M | 155.61M | 150.30M | 145.76M | 139.80M | 115.06M | 88.20M |
| Gross Profit Ratio | 31.00% | 23.49% | 31.35% | 41.44% | 32.15% | 31.88% | 33.68% | 31.19% | 31.19% | 29.58% | 27.18% |
| Research & Development | 36.06M | 36.68M | 39.25M | 35.67M | 29.19M | 26.10M | 19.15M | 9.59M | 7.19M | 7.21M | 7.26M |
| General & Administrative | 99.07M | 101.68M | 87.74M | 105.70M | 101.84M | 89.06M | 84.61M | 70.11M | 53.20M | 48.60M | 42.97M |
| Selling & Marketing | 38.93M | 31.97M | 37.68M | 54.73M | 32.12M | 27.71M | 23.07M | 15.49M | 14.40M | 14.79M | 11.48M |
| SG&A | 121.29M | 116.13M | 113.43M | 145.96M | 104.31M | 116.84M | 107.68M | 85.60M | 67.59M | 63.38M | 54.45M |
| Other Expenses | -539.00K | -2.52M | -11.70M | 5.68M | 2.60M | -2.70M | -448.00K | 0.00 | 0.00 | -1.77M | -1.52M |
| Operating Expenses | 174.61M | 155.34M | 164.38M | 181.63M | 133.49M | 116.85M | 130.46M | 97.78M | 70.76M | 61.62M | 52.94M |
| Cost & Expenses | 652.19M | 636.75M | 698.26M | 858.23M | 474.24M | 449.27M | 426.46M | 419.37M | 379.12M | 335.53M | 289.23M |
| Interest Income | 697.00K | 510.00K | 382.00K | 228.00K | 374.00K | 628.00K | 229.00K | 282.00K | 126.00K | 670.00K | 293.00K |
| Interest Expense | 1.68M | 2.85M | 2.43M | 3.40M | 2.86M | 810.00K | 361.00K | 339.00K | 5.00K | 40.00K | 80.00K |
| Depreciation & Amortization | 38.33M | 40.95M | 40.06M | 37.02M | 28.55M | 14.84M | 12.64M | 12.62M | 13.31M | 12.37M | 10.82M |
| EBITDA | 104.43M | 28.29M | 119.52M | 334.17M | 56.51M | 58.12M | 55.71M | 77.53M | 86.01M | 65.82M | 46.38M |
| EBITDA Ratio | 14.55% | 5.32% | 15.37% | 28.92% | 11.25% | 12.67% | 12.48% | 16.59% | 19.19% | 17.06% | 14.29% |
| Operating Income | 65.78M | -7.50M | 79.46M | 297.16M | 27.96M | 47.12M | 43.07M | 64.92M | 72.70M | 54.00M | 35.56M |
| Operating Income Ratio | 9.16% | -1.19% | 10.22% | 25.72% | 5.57% | 9.65% | 9.65% | 13.89% | 16.22% | 13.88% | 10.96% |
| Total Other Income/Expenses | 1.14M | -4.52M | -8.31M | -8.15M | -9.67M | -5.15M | -1.26M | -453.00K | -46.00K | 512.00K | -80.00K |
| Income Before Tax | 66.92M | -13.85M | 72.06M | 288.84M | 20.75M | 38.13M | 19.62M | 47.70M | 69.17M | 53.96M | 35.48M |
| Income Before Tax Ratio | 9.32% | -2.20% | 9.27% | 25.00% | 4.13% | 7.81% | 4.40% | 10.21% | 15.43% | 13.87% | 10.93% |
| Income Tax Expense | 8.71M | 2.87M | 6.11M | 36.65M | 5.44M | 3.93M | 8.16M | 10.61M | 2.48M | 11.56M | 8.47M |
| Net Income | 57.28M | -17.40M | 60.70M | 216.87M | 11.53M | 30.94M | 13.16M | 29.24M | 58.15M | 35.76M | 23.41M |
| Net Income Ratio | 7.98% | -2.76% | 7.80% | 18.77% | 2.29% | 6.34% | 2.95% | 6.26% | 12.98% | 9.19% | 7.22% |
| EPS | 0.09 | -0.03 | 0.09 | 0.34 | 0.02 | 0.05 | 0.02 | 0.05 | 0.14 | 0.07 | 0.05 |
| EPS Diluted | 0.09 | -0.03 | 0.09 | 0.33 | 0.02 | 0.05 | 0.02 | 0.05 | 0.14 | 0.07 | 0.05 |
| Weighted Avg Shares Out | 645.66M | 653.74M | 654.33M | 640.86M | 637.65M | 637.65M | 638.00M | 554.75M | 408.32M | 478.99M | 478.99M |
| Weighted Avg Shares Out (Dil) | 645.66M | 653.74M | 661.12M | 651.43M | 637.65M | 637.65M | 639.75M | 556.91M | 408.32M | 478.99M | 478.99M |
Source: https://incomestatements.info
Category: Stock Reports